The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Indications/Uses
Abrocitinib (Cibinqo) is indicated for the treatment of patients 12 years of age and older with moderate to severe atopic dermatitis, including the relief of pruritus, who have had an inadequate response to prescribed topical therapy or for whom these treatments are not advisable. Abrocitinib (Cibinqo) can be used with or without medicated topical therapies for atopic dermatitis.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
